Pregled bibliografske jedinice broj: 702471
Benefits of investment into modern medicines in Central-Eastern European countries
Benefits of investment into modern medicines in Central-Eastern European countries // Expert Review of Pharmacoeconomics & Outcomes Research, 14 (2014), 1; 71-79 doi:10.1586/14737167.2014.868314 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 702471 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Benefits of investment into modern medicines in Central-Eastern European countries
Autori
Inotai, András ; Petrova, Guenka ; Vitezić, Dinko ; Kaló, Zoltan
Izvornik
Expert Review of Pharmacoeconomics & Outcomes Research (1473-7167) 14
(2014), 1;
71-79
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
value of innovation ; innovative medicines ; middle income countries ; monetary benefit ; health gain ; productivity ; sustainability ; equity ; responsiveness ; financial protection
Sažetak
Due to the scarcity of health care resources, decision-makers often expect monetary benefits – including cost-savings or productivity gain - from innovative health technologies. Manufacturers try to fulfill this expectation by expressing the benefits of innovative technologies in monetary units citing approaches from the scientific literature. Unfortunately, currently available evidence has limited relevance and transferability in Central-Eastern European countries. This paper aims to summarize how innovative medical therapies in CEE countries may contribute to WHO-defined health system objectives, including health gain, equity in health, financial protection, responsiveness, equity in finance and financial sustainability. References in this paper are also mainly based on international examples ; therefore additional policy research from CEE countries is necessary to validate assumptions. If CEE politicians can rely on credible arguments based on local research evidence, they may improve long-term strategies and policy decisions related to health care innovation.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
062-0620063-0060 - Uporaba kardiovaskularnih lijekova i značaj farmakoekonomskih procjena (Vitezić, Dinko, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka
Profili:
Dinko Vitezić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE